Talaris Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch TALS and buy or sell other stocks, ETFs, and their options commission-free!

About TALS

Tourmaline Bio, Inc. is a late-stage clinical biotechnology company, which engages in the development of medicines for patients with life-altering immune diseases. It offers the TOUR006. 

CEO
Sandeep C. Kulkarni, MD
CEOSandeep C. Kulkarni, MD
Employees
74
Employees74
Headquarters
New York, New York
HeadquartersNew York, New York
Founded
2021
Founded2021
Employees
74
Employees74

TALS Key Statistics

Market cap
31.04M
Market cap31.04M
Price-Earnings ratio
-13.97
Price-Earnings ratio-13.97
Dividend yield
Dividend yield
Average volume
Average volume
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$48.27
52 Week high$48.27
52 Week low
$11.56
52 Week low$11.56

Stock Snapshot

The current Talaris Therapeutics(TALS) stock price is $1.21, with a market capitalization of 31.04M. The stock trades at a price-to-earnings (P/E) ratio of -13.97.

During the trading day, Talaris Therapeutics(TALS) stock saw an opening price of —, a peak of —, and a bottom of —.

Trading volume for Talaris Therapeutics(TALS) stock has reached 0.

The stock's 52-week range extends from a low of $11.56 to a high of $48.27.

The stock's 52-week range extends from a low of $11.56 to a high of $48.27.

People also own

Based on the portfolios of people who own TALS. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.